Direct-To-Consumer (DTC) Genetic Testing Market Analysis, Share And Growth 2025 To 2034


This study helps professionals make sense of complex market trends and competitive shifts affecting the direct-to-consumer (dtc) genetic testing industry today.

How Big Is The Direct-To-Consumer (DTC) Genetic Testing Market In 2025?
The direct-to-consumer (dtc) genetic testing market size has grown rapidly in recent years. It will grow from $1.84 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to curiosity about ancestry and heritage, health and wellness trends, marketing and consumer education, privacy and control over genetic data, affordability and accessibility.

The direct-to-consumer (dtc) genetic testing market size is expected to see rapid growth in the next few years. It will grow to $3.87 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to expanding test offerings, integration with personalized medicine, collaborations with health and wellness industries, advancements in genetic research, government support and regulations. Major trends in the forecast period include expanding test offerings and panels, educational initiatives for consumers, regulatory compliance and oversight, genomic data research and contributions, price reduction and accessibility.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

What Are The Major Factors Driving The Direct-To-Consumer (DTC) Genetic Testing Global Market Growth?
The rising prevalence of diseases and disorders with genetic transmission capabilities is expected to propel the growth of the direct-to-consumer (DTC) genetic testing market going forward. Genetic disorder refers to an illness caused by changes (mutation) in a person's DNA and it includes single-gene, multifactorial and chromosomal disorders. Direct-to-consumer genetic testing promotes awareness of various genetic disorders that helps in making predictions about health and provides personalized information about an individual’s health, disease risk, and other traits, thus, helps in taking effective health and lifestyle decisions to reduce the disease risk. For instance, in April 2023, the National Library of Medicine (NLM), a US-based medical library, published that an estimated 6.7 million Americans age 65 and older will be living with Alzheimer's dementia (AD), a disorder in which genetics play a significant role, in 2023. This number could grow to 13.8 million by 2060, barring the development of medical breakthroughs to prevent, slow, or cure AD. Therefore, the rising prevalence of diseases and disorders with genetic transmission capabilities is driving the growth of the direct-to-consumer (DTC) genetic testing market.

Direct-To-Consumer (DTC) Genetic Testing Market Report Segmentation Analysis
The direct-to-consumer (dtc) genetic testingmarket covered in this report is segmented –

1) By Type: Carrier Testing; Predictive Testing; Ancestry And Relationship Testing; Nutrigenomic Testing; Other Types
2) By Sample: Saliva; Urine; Blood
3) By Technology: Single Nucleotide Polymorphism Chips; Whole Genome Sequencing; Targeted Analysis
4) By Business Model: Health Planning Model; Comprehensive Genome Tests Model; Medical Precision Tests Model; Restricted Trait Tests Mode
5) By End User: Laboratories; Blood Banks; Nursing Homes; Hospitals; Imaging Centers; Home Care; Cosmetics; Other End-User

Subsegments:
1) By Carrier Testing: Autosomal Recessive Disorders; X-Linked Disorders
2) By Predictive Testing: Risk Assessment For Genetic Conditions; Adult-Onset Conditions
3) By Ancestry And Relationship Testing: Ancestry Composition Analysis; DNA Matching For Relationships
4) By Nutrigenomic Testing: Dietary Recommendations; Metabolism And Fitness Insights
5) By Other Types: Pharmacogenomic Testing; Health Trait Testing

Emerging Trends And Strategic Opportunities In The Direct-To-Consumer (DTC) Genetic Testing Market
Major companies operating in the direct-to-consumer (DTC) genetic testing market are focusing on investing in genetic research to sustain their position in the market. Investments provide the necessary financial backing for genetic testing companies to conduct research, enhance technologies, expand market reach, ensure compliance, and drive innovation. For instance, in November 2022, Redcliffe Labs, an India-based diagnostic centers & diagnosis labs, has announced its plan to invest an additional $10 million (around Rs 81 crore) towards the expansion of its genetic and specialized testing portfolio. This investment is intended to further develop the company's genetic testing capabilities, including areas such as prenatal, oncology, neurology, nephrology, and pharmacogenomics. The company has already invested $6 million in genetics and specialized testing coverage and is focused on next-generation technologies in the diagnostics space.

What Are The Top Players Operating In The Direct-To-Consumer (DTC) Genetic Testing Market?
Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme

View the full direct-to-consumer (dtc) genetic testing market report here:
https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Which Region Holds The Largest Market Share In The Direct-To-Consumer (DTC) Genetic Testing Market?
North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more